2-(4-Chloro-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

2-BROMO-6-FLUORO-4-(TRIFLUOROMETHYL)BENZALDEHYDE, 95%, 10g

3-(azidomethyl)pyridine, 95.0%, 250mg

2,4,6-Tris(diphenylamino)-5-fluoroisophthalonitrile, 97%, 100mg

2-((2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 1g

2-Piperidin-4-yl-benzooxazole, 95.0%, 1g

5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyrazine, 96%, 100mg

N,N-diméthylaniline, >=99%, pour la synthèse, 250 ml, emballage en verre

5-Bromo-4-methoxy-2-methylpyridine, 95.0%, 2.5g

Methyl 2,6-dichloronicotinate, 97.0%, 25g

2-Iodobenzothiazole, 95.0%, 1g

5-Amino-4-chloro-2-methyl-2,3-dihydropyridazin-3-one, 97%, 5g

(2E)-4-{[(tert-butoxy)carbonyl]amino}but-2-enoic acid, 95.0%, 1g